Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812795 · ClinicalTrials.gov registry record · NA
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
A NA study of Cigarette Smoking Behavior, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,214
- Enrollment target
- 2
- Study locations
NCT04812795: Completed NA study of Cigarette Smoking Behavior, sponsored by Abramson Cancer Center at Penn Medicine.
NCT04812795 is a NA study of Cigarette Smoking Behavior that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,214 participants, above the 435-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (409% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04812795, a NA study of Cigarette Smoking Behavior, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,214 participants
- Enrollment target
- 2
- Study locations
Study Summary
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Primary Outcome
Intention to quit smoking will be measured using the Burkhalter intention to quit smoking four item scale that measures readiness to cut down or quit smoking in the next 30 days at baseline and 1 month follow-up. Participants were asked to rate 4 statements: I will make an effort to quit smoking in the next 30 days (Unlikely to Likely); I intend to quit smoking in the next 30 days (Strongly disagree to Strongly Agree); I expect to quit smoking in the next 30 days (Definitely false to Definitely
Conditions Studied
Interventions
- OTHER Culturally tailored anti-smoking messages
- OTHER Non-culturally tailored interventions
Study Locations (2)
California
- Stanford University - Stanford
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,214 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2022-06-20 |
| Phase | NA |
What the finished NCT04812795 record still lists
NCT04812795 is an interventional study that assigns participants to a tested intervention. Its 2,214 participants enrollment target places it among the larger protocols in the corpus, above the 435-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (409% higher).
The record links to 1 condition, with Cigarette Smoking Behavior appearing as the primary indexed condition, and to 2 interventions - of which Culturally tailored anti-smoking messages is the first listed.
NCT04812795 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04812795 about?
NCT04812795 is a clinical study titled "Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches". Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support late...
What is the current status of trial NCT04812795?
This trial is currently completed. It is a NA study. The enrollment target is 2,214 participants. The study started on 2021-09-08. Estimated completion is 2022-06-20.
What conditions does trial NCT04812795 study?
This clinical trial studies the following conditions: Cigarette Smoking Behavior.
What interventions are being tested in trial NCT04812795?
The interventions under investigation include: Culturally tailored anti-smoking messages (OTHER), Non-culturally tailored interventions (OTHER).
Who is sponsoring clinical trial NCT04812795?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04812795 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
RECRUITING · NA
-
An Experimental Evaluation of Menthol-Flavored Tobacco Accessories
ACTIVE NOT RECRUITING · NA
-
Enhancing Source Credibility in Tobacco Regulatory Communications
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI